Matej Sova

2.9k total citations · 2 hit papers
53 papers, 2.3k citations indexed

About

Matej Sova is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Matej Sova has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 20 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Matej Sova's work include Genomics, phytochemicals, and oxidative stress (6 papers), Immune Response and Inflammation (6 papers) and Antimicrobial Peptides and Activities (5 papers). Matej Sova is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (6 papers), Immune Response and Inflammation (6 papers) and Antimicrobial Peptides and Activities (5 papers). Matej Sova collaborates with scholars based in Slovenia, France and Italy. Matej Sova's co-authors include Stanislav Gobec, Luciano Saso, Andreja Kovač, Didier Blanot, Hélène Barreteau, Audrey Boniface, Marko Jukič, Samo Turk, Sebahattin Ergün and Sevdan Yılmaz and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and FEMS Microbiology Reviews.

In The Last Decade

Matej Sova

53 papers receiving 2.3k citations

Hit Papers

Cytoplasmic steps of pept... 2008 2026 2014 2020 2008 2012 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Matej Sova 1.1k 581 287 287 278 53 2.3k
Cristina Airoldi 1.2k 1.1× 517 0.9× 148 0.5× 233 0.8× 73 0.3× 100 2.3k
Vikas Jaitak 1.0k 1.0× 1.1k 1.9× 659 2.3× 605 2.1× 113 0.4× 95 3.1k
Vibha Tandon 832 0.8× 843 1.5× 127 0.4× 298 1.0× 87 0.3× 93 2.5k
Mаhmoud Youns 1.0k 1.0× 610 1.0× 223 0.8× 328 1.1× 52 0.2× 49 2.3k
Chunyan Han 589 0.5× 225 0.4× 149 0.5× 292 1.0× 109 0.4× 27 1.9k
Martin Zehl 1.4k 1.3× 260 0.4× 204 0.7× 517 1.8× 96 0.3× 112 2.7k
Mohammad M. Al‐Sanea 819 0.8× 760 1.3× 286 1.0× 247 0.9× 39 0.1× 119 2.2k
Sheng‐Xiang Qiu 1.8k 1.7× 722 1.2× 319 1.1× 1.1k 4.0× 167 0.6× 156 3.7k
Woo Song Lee 1.7k 1.6× 833 1.4× 333 1.2× 638 2.2× 75 0.3× 117 4.5k
Bhadrapura Lakkappa Dhananjaya 647 0.6× 224 0.4× 129 0.4× 227 0.8× 397 1.4× 55 1.8k

Countries citing papers authored by Matej Sova

Since Specialization
Citations

This map shows the geographic impact of Matej Sova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matej Sova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matej Sova more than expected).

Fields of papers citing papers by Matej Sova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matej Sova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matej Sova. The network helps show where Matej Sova may publish in the future.

Co-authorship network of co-authors of Matej Sova

This figure shows the co-authorship network connecting the top 25 collaborators of Matej Sova. A scholar is included among the top collaborators of Matej Sova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matej Sova. Matej Sova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steinebach, Christian, et al.. (2025). Targeting TAK1: Evolution of inhibitors, challenges, and future directions. Pharmacology & Therapeutics. 267. 108810–108810. 2 indexed citations
2.
Sosič, Izidor, et al.. (2025). Optimization of 6-(trifluoromethyl)pyrimidine derivatives as TLR8 antagonists. Acta Pharmaceutica. 75(2). 159–183. 1 indexed citations
3.
Švajger, Urban, et al.. (2024). Structural Optimization and Biological Evaluation of Isoxazolo[5,4-d]pyrimidines as Selective Toll-Like Receptor 7 Agonists. ACS Omega. 9(2). 2362–2382. 2 indexed citations
4.
Stroylov, Viktor S., et al.. (2023). Substituted cinnamides: Characterization of non-toxic inhibitors of alpha-synuclein aggregation. Mendeleev Communications. 33(3). 334–336. 2 indexed citations
5.
Gallorini, Marialucia, Simone Carradori, Emiliano Panieri, Matej Sova, & Luciano Saso. (2023). Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications. Antioxidants and Redox Signaling. 40(10-12). 636–662. 18 indexed citations
6.
Gobec, Stanislav, et al.. (2020). Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets. Pharmacology & Therapeutics. 221. 107746–107746. 55 indexed citations
7.
Švajger, Urban, et al.. (2019). Selective Toll-like receptor 7 agonists with novel chromeno[3,4-d]imidazol-4(1H)-one and 2-(trifluoromethyl)quinoline/ quinazoline-4-amine scaffolds. European Journal of Medicinal Chemistry. 179. 109–122. 17 indexed citations
8.
Sova, Matej & Luciano Saso. (2018). Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review. Drug Design Development and Therapy. Volume 12. 3181–3197. 78 indexed citations
9.
Knez, Damijan, Nicolas Coquelle, Anja Pišlar, et al.. (2018). Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. European Journal of Medicinal Chemistry. 156. 598–617. 79 indexed citations
10.
Lešnik, Samo, Boris Brus, Martina Hrast, et al.. (2017). Discovery of new MurA inhibitors using induced-fit simulation and docking. Bioorganic & Medicinal Chemistry Letters. 27(4). 944–949. 23 indexed citations
11.
Sova, Matej, et al.. (2016). Synthesis and Biological Evaluation of N-Aryl-N'-(5-(2-hydroxybenzoyl) pyrimidin-2-yl)guanidines as Toll-Like Receptor 4 Antagonists. Medicinal Chemistry. 12(8). 742–750. 4 indexed citations
12.
Berne, Sabina, Lidija Kovačič, Matej Sova, et al.. (2015). Benzoic acid derivatives with improved antifungal activity: Design, synthesis, structure–activity relationship (SAR) and CYP53 docking studies. Bioorganic & Medicinal Chemistry. 23(15). 4264–4276. 17 indexed citations
13.
Sova, Matej, Željko Žižak, Jelena Antić‐Stanković, et al.. (2013). Cinnamic Acid Derivatives Induce Cell Cycle Arrest in Carcinoma Cell Lines. Medicinal Chemistry. 9(5). 633–641. 25 indexed citations
14.
Švajger, Urban, Boris Brus, Samo Turk, et al.. (2013). Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening. European Journal of Medicinal Chemistry. 70. 393–399. 39 indexed citations
15.
Sova, Matej. (2012). Antioxidant and Antimicrobial Activities of Cinnamic Acid Derivatives. Mini-Reviews in Medicinal Chemistry. 12(8). 749–767. 449 indexed citations breakdown →
16.
Sova, Matej, Andreja Kovač, Samo Turk, et al.. (2009). Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF. Bioorganic Chemistry. 37(6). 217–222. 39 indexed citations
17.
Barreteau, Hélène, Andreja Kovač, Audrey Boniface, et al.. (2008). Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiology Reviews. 32(2). 168–207. 545 indexed citations breakdown →
18.
Kristan, Katja, et al.. (2008). Novel inhibitors of β-ketoacyl-ACP reductase from Escherichia coli. Chemico-Biological Interactions. 178(1-3). 310–316. 13 indexed citations
19.
Brožič, Petra, Petra Kocbek, Matej Sova, et al.. (2008). Flavonoids and cinnamic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1. Molecular and Cellular Endocrinology. 301(1-2). 229–234. 48 indexed citations
20.
Sova, Matej, Andrej Perdih, Miha Kotnik, et al.. (2006). Flavonoids and cinnamic acid esters as inhibitors of fungal 17β-hydroxysteroid dehydrogenase: A synthesis, QSAR and modelling study. Bioorganic & Medicinal Chemistry. 14(22). 7404–7418. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026